‘SILVAMP TB LAM’ rapid urine tuberculosis test predicts mortality in hospitalized HIV patients in South Africa
File(s)ciaa024.pdf (278.68 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Reducing diagnostic delay is key towards decreasing tuberculosis-associated deaths in people living with HIV. In tuberculosis patients with retrospective urine testing, the point-of-care Fujifilm SILVAMP TB LAM (FujiLAM) could have rapidly diagnosed tuberculosis in up to 89% who died. In FujiLAM negative patients, the probability of 12-week survival was 86-97%.
Date Issued
2020-10-15
Date Acceptance
2020-01-01
Citation
Clinical Infectious Diseases, 2020, 71 (8), pp.1973-1976
ISSN
1058-4838
Publisher
Oxford University Press (OUP)
Start Page
1973
End Page
1976
Journal / Book Title
Clinical Infectious Diseases
Volume
71
Issue
8
Copyright Statement
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium,
provided the original work is properly cited.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium,
provided the original work is properly cited.
License URL
Sponsor
Wellcome Trust
Identifier
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa024/5699650
Grant Number
104803/Z/14/Z
Subjects
HIV
Tuberculosis
lipoarabinomannan
mortality
point-of-care
Microbiology
06 Biological Sciences
11 Medical and Health Sciences
Publication Status
Published
Date Publish Online
2020-01-09